Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Biotech
Vertex inches closer to acute pain market as FDA accepts VX-548
Vertex is inching closer to bringing a non-opioid pain med to market, with the FDA accepting an NDA submission for VX-548, now dubbed suzetrigine.
Gabrielle Masson
Apr 18, 2024 10:50am
FDA hands de novo clearance to Scopio's bone marrow pathology AI
Apr 17, 2024 12:56pm
FDA aims to boost trial innovation with new center at CDER
Apr 17, 2024 10:03am
FDA confers clearances to 2 novel antibacterial implant coatings
Apr 15, 2024 2:07pm
Roche, Lilly blood test for Alzheimer's expedited at FDA
Apr 11, 2024 11:06am
US court hands Philips final consent decree in CPAP recall
Apr 10, 2024 11:49am